Multi-omic Characterization of Pancreatic Cancer-Associated Macrophage Polarization Reveals Deregulated Metabolic Programs Driven by the GMCSF-PI3K Pathway

The pancreatic ductal adenocarcinoma (PDA) microenvironment is composed of a variety of cell types and marked by extensive fibrosis and inflammation. Tumor-associated macrophages (TAM) are abundant, and they are important mediators of disease progression and invasion. TAMs are polarized in situ to a tumor promoting and immunosuppressive phenotype via cytokine signaling and metabolic crosstalk from malignant epithelial cells and other components of the tumor microenvironment (TME). However, the specific distinguishing features and functions of TAMs remain poorly defined. Here, we generated tumor-educated macrophages (TEM) in vitro and performed detailed, multi-omic characterization (i.e. transcriptomics, proteomics, metabolomics). Our results reveal unique genetic and metabolic signatures of TEMs, the veracity of which were queried against our in-house single cell RNA sequencing (scRNA-seq) dataset of human pancreatic tumors. This analysis identified expression of novel, metabolic TEM markers in human pancreatic TAMs, including ARG1, ACLY, and TXNIP. We then utilized our TEM model system to study the role of mutant Kras signaling in cancer cells on TEM polarization. This revealed an important role for GM-CSF and lactate on TEM polarization, molecules released from cancer cells in a mutant Kras-dependent manner. Lastly, we demonstrate that GM-CSF dysregulates TEM gene expression and metabolism through PI3K-AKT pathway signaling. Collectively, our results define new markers and programs to classify pancreatic TAMs, how these are engaged by cancer cells, and the precise signaling pathways mediating polarization.

[1]  J. Scheller,et al.  Lactate and IL6 define separable paths of inflammatory metabolic adaptation , 2021, Science Advances.

[2]  D. Molenaar,et al.  Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques , 2020, Nature Communications.

[3]  W. Liang,et al.  Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma , 2020, Aging.

[4]  Jessica S. Yu,et al.  Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer , 2020, Nature Cancer.

[5]  Alexey I. Nesvizhskii,et al.  Philosopher: a versatile toolkit for shotgun proteomics data analysis , 2020, Nature Methods.

[6]  D. Aldinucci,et al.  The CCL5/CCR5 Axis in Cancer Progression , 2020, Cancers.

[7]  Alexey I. Nesvizhskii,et al.  Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors , 2020, Nature Communications.

[8]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[9]  A. Lew,et al.  The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game , 2019, Front. Immunol..

[10]  B. Ren,et al.  Metabolic regulation of gene expression by histone lactylation , 2019, Nature.

[11]  J. Hamilton.  GM-CSF-Dependent Inflammatory Pathways , 2019, Front. Immunol..

[12]  Chandler D. Gatenbee,et al.  Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer , 2019, British Journal of Cancer.

[13]  Ho-Joon Lee,et al.  A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics , 2019, Metabolomics.

[14]  K. Ley,et al.  Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages , 2019, Front. Immunol..

[15]  Tai-Gyu Kim,et al.  GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease , 2019, Front. Immunol..

[16]  Jing-Song Chen,et al.  PIK3CD induces cell growth and invasion by activating AKT/GSK‐3β/β‐catenin signaling in colorectal cancer , 2019, Cancer science.

[17]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[18]  R. Weissleder,et al.  Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages , 2018, Theranostics.

[19]  Ho-Joon Lee,et al.  Macrophage Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer , 2018, bioRxiv.

[20]  A. Biankin,et al.  CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype , 2018, Cell reports.

[21]  G. Storm,et al.  Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Jingqin Luo,et al.  Tissue‐Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression , 2017, Immunity.

[23]  N. Perrimon,et al.  Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation. , 2017, Cell reports.

[24]  Alexey I Nesvizhskii,et al.  MSFragger: ultrafast and comprehensive peptide identification in shotgun proteomics , 2017, Nature Methods.

[25]  M. Pasca di Magliano,et al.  Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer , 2016, Gut.

[26]  Crispin J. Miller,et al.  Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation , 2016, Cell.

[27]  Dudley Lamming,et al.  Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation , 2016, eLife.

[28]  P. Allavena,et al.  Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy , 2015, Gut.

[29]  C. Clendenin,et al.  Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages. , 2015, Gastroenterology.

[30]  D. Linehan,et al.  CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. , 2015, Cancer research.

[31]  Abhishek K. Jha,et al.  Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. , 2015, Immunity.

[32]  G. Cline,et al.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.

[33]  E. Diamandis,et al.  Strategies for discovering novel pancreatic cancer biomarkers. , 2013, Journal of proteomics.

[34]  A. Shaywitz,et al.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. , 2013, Molecular cell.

[35]  Derek S. Chan,et al.  The Pancreas Cancer Microenvironment , 2012, Clinical Cancer Research.

[36]  J. Swinnen,et al.  ATP-citrate lyase: a key player in cancer metabolism. , 2012, Cancer research.

[37]  N. Jhala,et al.  Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. , 2012, Cancer cell.

[38]  D. Bar-Sagi,et al.  Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. , 2012, Cancer cell.

[39]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[40]  C. Galbán,et al.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.

[41]  A. Mantovani,et al.  Cancer-related inflammation: common themes and therapeutic opportunities. , 2012, Seminars in cancer biology.

[42]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[43]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[44]  M. Lopes-Virella,et al.  Lactate Boosts TLR4 Signaling and NF-κB Pathway-Mediated Gene Transcription in Macrophages via Monocarboxylate Transporters and MD-2 Up-Regulation1 , 2009, The Journal of Immunology.

[45]  I. Buschmann,et al.  Divergent effects of GM‐CSF and TGFβ1 on bone marrow‐ derived macrophage arginase‐1 activity, MCP‐1 expression, and matrix‐metalloproteinase‐12: a potential role during arteriogenesis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  RiceDerik.  More Than a Numbers Game , 2003 .

[47]  I. Julkunen,et al.  Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)‐induced STAT5 activation and target‐gene expression during human monocyte/macrophage differentiation , 2002, Journal of leukocyte biology.

[48]  R. Schreiber,et al.  Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity , 1984, The Journal of experimental medicine.

[49]  P. Murray.  Macrophage Polarization. , 2017, Annual review of physiology.

[50]  Jingqin Luo,et al.  Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. , 2017, Immunity.

[51]  D. Linehan,et al.  Microenvironment and Immunology CSF 1 / CSF 1 R Blockade Reprograms Tumor-In fi ltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models , 2014 .